Search Within

Angela Kellen Green

  1. "Population Sciences Research Program"
Formats
  1. Journal Article (18)
  2. Meeting Abstract (15)
  3. Editorial (3)
  4. Review (3)
  5. Book Section (1)
Groups
  1. Department of Medicine (40)
  2. GDMT, Medicine (40)
  3. Gynecologic Medicine Service (40)
  4. Gynecology Disease Management Team (40)
  5. Population Sciences Research Program (40)
  6. Solid Tumor Oncology Division (40)

More Groups

People
  1. Vicky Makker (12)
  2. Carol Aghajanian (10)
  3. Peter Bach (10)
  4. Maria Zlobinsky (7)
  5. Sham Mailankody (6)
  6. Paul Sabbatini (5)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Gynecologic Oncology (8)
  3. International Journal of Gynecological Cancer (4)
  4. JAMA Network Open (3)
  5. Journal of the National Comprehensive Cancer Network (3)
  6. American Society of Clinical Oncology Educational Book (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Elsevier Inc. (8)
  3. American Medical Association (4)
  4. Lippincott Williams & Wilkins (4)
  5. Harborside Press (3)
  6. Springer (2)

More Publishers

Results (40)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of fulvestrant and abemaciclib in hormone receptor positive advanced or recurrent endometrial cancer
    Meeting Abstract

    Green, A.; Zhou, Q.; Iasonos, A.; Zammarrelli, W.; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Hom, V.; Erinjeri, J. P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Priebe, A.; Duska, L.; Green, A.; Mathews, C.; Musa, F.; O'Malley, D.; Puechl, A.; Ding, L.; Schmid, A.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns in recurrent or advanced endometrial cancer patients on first-line systemic therapy in the United States
    Meeting Abstract

    Ogando, Y. M.; Chen, L.; Zhang, J.; Kelkar, S. S.; Prabhu, V. S.; Miles, N.; Green, A.; Makker, V.
    Pharmacoepidemiology and Drug Safety (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of etigilimab (anti-TIGIT) with nivolumab (anti-PD1) in recurrent/advanced solid tumors
    Meeting Abstract

    McKean, M.; Dumbrava, E. E.; Hamid, O.; Merriam, P.; Call, J. A.; Feely, W.; Green, A.; Vaishampayan, U. N.; Moore, K. N.; Weroha, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Real-world outcomes and adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Ma, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N.; Aghajanian, C.; Green, A.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Current evidence-based systemic therapy for advanced and recurrent endometrial cancer
    Review

    Gordhandas, S.; Zammarrelli, W. A. 3rd; Rios-Doria, E. V.; Green, A. K.; Makker, V.
    Journal of the National Comprehensive Cancer Network (2023)

    Fulltext@MSK | Save
  • Real-world experience and common adverse events when using combination lenvatinib and pembrolizumab for the treatment of recurrent uterine cancer
    Meeting Abstract

    Zammarrelli, W.; Espino, K.; Yeoshoua, E.; Ehmann, S.; Rubinstein, M.; Green, A.; Makker, V.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Clinical trial participation among older adult Medicare fee-for-service beneficiaries with cancer
    Journal Article

    Green, A. K.; Tabatabai, S. M.; Aghajanian, C.; Landgren, O.; Riely, G. J.; Sabbatini, P.; Bach, P. B.; Begg, C. B.; Lipitz-Snyderman, A.; Mailankody, S.
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save